Unknown

Dataset Information

0

Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2.

ABSTRACT:

SUBMITTER: Tenbusch M 

PROVIDER: S-EPMC8321428 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Heterologous ChAdOx1 nCoV-19/BNT162b2 Prime-Boost Vaccination Induces Strong Humoral Responses among Health Care Workers.
| S-EPMC8402499 | biostudies-literature
Unknown Evaluation of Antibody Response to Heterologous Prime-Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study.
| S-EPMC8704060 | biostudies-literature
Unknown Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
| S-EPMC8682749 | biostudies-literature
Unknown Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study.
| S-EPMC8360702 | biostudies-literature
Unknown Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study.
| S-EPMC8520818 | biostudies-literature
Unknown Increased neutralization of SARS-CoV-2 Delta variant after heterologous ChAdOx1 nCoV-19/BNT162b2 versus homologous BNT162b2 vaccination.
| S-EPMC8730691 | biostudies-literature
Unknown Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
| S-EPMC8314734 | biostudies-literature
Unknown Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.
| S-EPMC8440184 | biostudies-literature
Unknown Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination.
| S-EPMC8440177 | biostudies-literature
Unknown Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination.
| S-EPMC8381713 | biostudies-literature